** Shares of Proteomics International Laboratories surge as much as 24% to A$0.750, their biggest one-day pct gain since Oct. 8
** Medical technology firm reports that its PromarkerEndo plasma protein biomarker panel accurately identifies all stages of endometriosis
** Endometriosis is a condition causing uterine-like tissue growth outside the uterus, affecting roughly 10% of reproductive age women and girls according to the WHO
** The condition takes an average of seven years to diagnose
** PIQ sets sights on Q2 CY25 for Australian launch of its product
** Stock hits its highest level since Oct. 29
** Including session's moves, stock trims YTD losses to 19% as of 0050 GMT
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。